NO781473L - Polymermatriks basert paa akrylamid. - Google Patents
Polymermatriks basert paa akrylamid.Info
- Publication number
- NO781473L NO781473L NO78781473A NO781473A NO781473L NO 781473 L NO781473 L NO 781473L NO 78781473 A NO78781473 A NO 78781473A NO 781473 A NO781473 A NO 781473A NO 781473 L NO781473 L NO 781473L
- Authority
- NO
- Norway
- Prior art keywords
- acrylamide
- polymer matrix
- antibody
- methacrylic acid
- copolymer
- Prior art date
Links
- 239000011159 matrix material Substances 0.000 title claims description 35
- 229920000642 polymer Polymers 0.000 title claims description 33
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 title claims description 22
- 229920001577 copolymer Polymers 0.000 claims description 19
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 claims description 18
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 12
- 229940088597 hormone Drugs 0.000 claims description 12
- 239000005556 hormone Substances 0.000 claims description 12
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 claims description 11
- 150000003839 salts Chemical class 0.000 claims description 10
- 239000003814 drug Substances 0.000 claims description 8
- 150000001875 compounds Chemical class 0.000 claims description 4
- FQPSGWSUVKBHSU-UHFFFAOYSA-N methacrylamide Chemical compound CC(=C)C(N)=O FQPSGWSUVKBHSU-UHFFFAOYSA-N 0.000 claims description 4
- 239000003513 alkali Substances 0.000 claims description 3
- 239000000243 solution Substances 0.000 description 15
- 230000027455 binding Effects 0.000 description 9
- 239000000178 monomer Substances 0.000 description 9
- 239000000126 substance Substances 0.000 description 8
- 229960001348 estriol Drugs 0.000 description 7
- 239000002253 acid Substances 0.000 description 6
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 210000002966 serum Anatomy 0.000 description 6
- 229940034208 thyroxine Drugs 0.000 description 6
- PROQIPRRNZUXQM-UHFFFAOYSA-N (16alpha,17betaOH)-Estra-1,3,5(10)-triene-3,16,17-triol Natural products OC1=CC=C2C3CCC(C)(C(C(O)C4)O)C4C3CCC2=C1 PROQIPRRNZUXQM-UHFFFAOYSA-N 0.000 description 5
- XUIIKFGFIJCVMT-GFCCVEGCSA-N D-thyroxine Chemical compound IC1=CC(C[C@@H](N)C(O)=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-GFCCVEGCSA-N 0.000 description 5
- 230000002860 competitive effect Effects 0.000 description 5
- 230000009260 cross reactivity Effects 0.000 description 5
- PROQIPRRNZUXQM-ZXXIGWHRSA-N estriol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H]([C@H](O)C4)O)[C@@H]4[C@@H]3CCC2=C1 PROQIPRRNZUXQM-ZXXIGWHRSA-N 0.000 description 5
- 238000011534 incubation Methods 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 229920002401 polyacrylamide Polymers 0.000 description 5
- XUIIKFGFIJCVMT-UHFFFAOYSA-N thyroxine-binding globulin Natural products IC1=CC(CC([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-UHFFFAOYSA-N 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- 229960000890 hydrocortisone Drugs 0.000 description 4
- 239000008363 phosphate buffer Substances 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 229920006322 acrylamide copolymer Polymers 0.000 description 3
- 230000001900 immune effect Effects 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 238000006116 polymerization reaction Methods 0.000 description 3
- 239000000700 radioactive tracer Substances 0.000 description 3
- 150000003431 steroids Chemical class 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 102000014914 Carrier Proteins Human genes 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 102000057297 Pepsin A Human genes 0.000 description 2
- 108090000284 Pepsin A Proteins 0.000 description 2
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
- AUYYCJSJGJYCDS-LBPRGKRZSA-N Thyrolar Chemical compound IC1=CC(C[C@H](N)C(O)=O)=CC(I)=C1OC1=CC=C(O)C(I)=C1 AUYYCJSJGJYCDS-LBPRGKRZSA-N 0.000 description 2
- ZORQMBLUMWNJEQ-ZXXIGWHRSA-N [(8r,9s,13s,14s,16r,17r)-16,17-dihydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl] hydrogen sulfate Chemical compound OS(=O)(=O)OC1=CC=C2[C@H]3CC[C@](C)([C@H]([C@H](O)C4)O)[C@@H]4[C@@H]3CCC2=C1 ZORQMBLUMWNJEQ-ZXXIGWHRSA-N 0.000 description 2
- 108091008324 binding proteins Proteins 0.000 description 2
- 238000007334 copolymerization reaction Methods 0.000 description 2
- DOBMPNYZJYQDGZ-UHFFFAOYSA-N dicoumarol Chemical compound C1=CC=CC2=C1OC(=O)C(CC=1C(OC3=CC=CC=C3C=1O)=O)=C2O DOBMPNYZJYQDGZ-UHFFFAOYSA-N 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 229940111202 pepsin Drugs 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 159000000001 potassium salts Chemical class 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 238000000638 solvent extraction Methods 0.000 description 2
- 229940035722 triiodothyronine Drugs 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- DNXHEGUUPJUMQT-UHFFFAOYSA-N (+)-estrone Natural products OC1=CC=C2C3CCC(C)(C(CC4)=O)C4C3CCC2=C1 DNXHEGUUPJUMQT-UHFFFAOYSA-N 0.000 description 1
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 1
- HGUFODBRKLSHSI-UHFFFAOYSA-N 2,3,7,8-tetrachloro-dibenzo-p-dioxin Chemical compound O1C2=CC(Cl)=C(Cl)C=C2OC2=C1C=C(Cl)C(Cl)=C2 HGUFODBRKLSHSI-UHFFFAOYSA-N 0.000 description 1
- PBMWEQHOZPTUQQ-UHFFFAOYSA-N 4-hydroxy-2-methylbut-2-enamide Chemical compound NC(=O)C(C)=CCO PBMWEQHOZPTUQQ-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- WDJUZGPOPHTGOT-OAXVISGBSA-N Digitoxin Natural products O([C@H]1[C@@H](C)O[C@@H](O[C@@H]2C[C@@H]3[C@@](C)([C@@H]4[C@H]([C@]5(O)[C@@](C)([C@H](C6=CC(=O)OC6)CC5)CC4)CC3)CC2)C[C@H]1O)[C@H]1O[C@@H](C)[C@H](O[C@H]2O[C@@H](C)[C@@H](O)[C@@H](O)C2)[C@@H](O)C1 WDJUZGPOPHTGOT-OAXVISGBSA-N 0.000 description 1
- DNXHEGUUPJUMQT-CBZIJGRNSA-N Estrone Chemical compound OC1=CC=C2[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 DNXHEGUUPJUMQT-CBZIJGRNSA-N 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KWYHDKDOAIKMQN-UHFFFAOYSA-N N,N,N',N'-tetramethylethylenediamine Chemical compound CN(C)CCN(C)C KWYHDKDOAIKMQN-UHFFFAOYSA-N 0.000 description 1
- JGQGQGUIMKZTPF-UHFFFAOYSA-N NC1=CC=CC=C1.C1=CC=C2C(O)=CC=CC2=C1 Chemical compound NC1=CC=CC=C1.C1=CC=C2C(O)=CC=CC2=C1 JGQGQGUIMKZTPF-UHFFFAOYSA-N 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- VEUACKUBDLVUAC-UHFFFAOYSA-N [Na].[Ca] Chemical compound [Na].[Ca] VEUACKUBDLVUAC-UHFFFAOYSA-N 0.000 description 1
- 239000003929 acidic solution Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 150000003926 acrylamides Chemical class 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 229940097217 cardiac glycoside Drugs 0.000 description 1
- 239000002368 cardiac glycoside Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000037029 cross reaction Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 229960001912 dicoumarol Drugs 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 229960000648 digitoxin Drugs 0.000 description 1
- WDJUZGPOPHTGOT-XUDUSOBPSA-N digitoxin Chemical compound C1[C@H](O)[C@H](O)[C@@H](C)O[C@H]1O[C@@H]1[C@@H](C)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@@H]3C[C@@H]4[C@]([C@@H]5[C@H]([C@]6(CC[C@@H]([C@@]6(C)CC5)C=5COC(=O)C=5)O)CC4)(C)CC3)C[C@@H]2O)C)C[C@@H]1O WDJUZGPOPHTGOT-XUDUSOBPSA-N 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000009881 electrostatic interaction Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 229960005309 estradiol Drugs 0.000 description 1
- 229930182833 estradiol Natural products 0.000 description 1
- UZKIAJMSMKLBQE-JRSYHJKYSA-N estriol 3-O-(beta-D-glucuronide) Chemical compound C([C@@H]1[C@@H](C2=CC=3)CC[C@]4([C@H]1C[C@@H](O)[C@@H]4O)C)CC2=CC=3O[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O UZKIAJMSMKLBQE-JRSYHJKYSA-N 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 229960003399 estrone Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 150000008134 glucuronides Chemical group 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 229920003145 methacrylic acid copolymer Polymers 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 230000009871 nonspecific binding Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000186 progesterone Substances 0.000 description 1
- 229960003387 progesterone Drugs 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000010526 radical polymerization reaction Methods 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 1
- 229960001860 salicylate Drugs 0.000 description 1
- 150000003873 salicylate salts Chemical class 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 229930002534 steroid glycoside Natural products 0.000 description 1
- 239000003270 steroid hormone Substances 0.000 description 1
- 150000008143 steroidal glycosides Chemical class 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-N sulfonic acid Chemical compound OS(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-N 0.000 description 1
- 229910021653 sulphate ion Inorganic materials 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229960003604 testosterone Drugs 0.000 description 1
- 239000005495 thyroid hormone Substances 0.000 description 1
- 229940036555 thyroid hormone Drugs 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 229960004441 tyrosine Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940082632 vitamin b12 and folic acid Drugs 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/544—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic
- G01N33/545—Synthetic resin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/44—Antibodies bound to carriers
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/807—Apparatus included in process claim, e.g. physical support structures
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/815—Test for named compound or class of compounds
- Y10S436/817—Steroids or hormones
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Cell Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Public Health (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Paints Or Removers (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2721267A DE2721267C2 (de) | 1977-05-11 | 1977-05-11 | Antikörpergel |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO781473L true NO781473L (no) | 1978-11-14 |
Family
ID=6008655
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO78781473A NO781473L (no) | 1977-05-11 | 1978-04-26 | Polymermatriks basert paa akrylamid. |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US4235867A (sv) |
| JP (1) | JPS5417116A (sv) |
| AT (1) | AT364856B (sv) |
| AU (1) | AU519148B2 (sv) |
| BE (1) | BE866491A (sv) |
| BR (1) | BR7802600A (sv) |
| CH (1) | CH637218A5 (sv) |
| DD (1) | DD136185A5 (sv) |
| DE (1) | DE2721267C2 (sv) |
| DK (1) | DK181478A (sv) |
| ES (1) | ES469830A1 (sv) |
| FI (1) | FI781220A (sv) |
| FR (1) | FR2390731A1 (sv) |
| GB (1) | GB1603772A (sv) |
| GR (1) | GR64474B (sv) |
| HU (1) | HU178485B (sv) |
| IL (1) | IL54558A (sv) |
| LU (1) | LU79535A1 (sv) |
| NL (1) | NL7804466A (sv) |
| NO (1) | NO781473L (sv) |
| NZ (1) | NZ187071A (sv) |
| PL (1) | PL121950B1 (sv) |
| SE (1) | SE7804801L (sv) |
| ZA (1) | ZA782358B (sv) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2458070A1 (fr) * | 1979-05-28 | 1980-12-26 | Compiegne Inst Technol Surf Ac | Dispositif pour l'identification et le dosage de substances biochimiques antigeniques dans les fluides biologiques |
| WO1981002343A1 (en) * | 1980-02-05 | 1981-08-20 | Japan Atomic Energy Res Inst | Unit system for use in medical analysis and process for preparing same |
| JPS5729949A (en) * | 1980-07-30 | 1982-02-18 | Nippon Koutai Kenkyusho:Kk | Determination of sugar branch related to cancer and diagnostic technique of cancer |
| US4540660A (en) * | 1983-04-07 | 1985-09-10 | Daryl Laboratories, Inc. | Substrate for fluoroimmunoassay of biological fluids |
| JPS61228351A (ja) * | 1985-04-02 | 1986-10-11 | Kyoto Ikagaku Kenkyusho:Kk | 糞便中のヘモグロビンの検出方法 |
| AU7309487A (en) * | 1986-04-30 | 1987-11-24 | Baylor College Of Medicine | Polyamide resin and method for preparation of reagents for immunodiagnostic use |
| DE3921498A1 (de) * | 1988-09-28 | 1990-03-29 | Bayer Ag | Polymer-gebundene-farbstoffe, verfahren zu deren herstellung und verwendung |
| US5149737A (en) * | 1990-06-18 | 1992-09-22 | Eastman Kodak Company | Carboxy containing monomers and polymers and latices prepared from same |
| US5210289A (en) * | 1990-06-18 | 1993-05-11 | Eastman Kodak Company | Carboxy containing monomers |
| US5262297A (en) * | 1990-06-18 | 1993-11-16 | Eastman Kodak Company | Specific binding analytical and separation methods using carboxy containing polymers |
| US5147777A (en) * | 1990-06-18 | 1992-09-15 | Eastman Kodak Company | Biologically active reagents prepared from carboxy-containing polymer, analytical element and methods of use |
| US5424219A (en) * | 1991-10-25 | 1995-06-13 | Cytech Biomedical, Inc. | Method of performing assays for biomolecules and solid supports for use in such methods |
| EP2192409B1 (en) * | 2008-11-26 | 2014-04-23 | Corning Incorporated | Label independent detection biosensor composition and methods thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3925017A (en) * | 1973-05-01 | 1975-12-09 | Wisconsin Alumni Res Found | Preparation of dry, porous gel particles having high water regain for liquid sampling |
| US4061466A (en) * | 1974-10-16 | 1977-12-06 | Ingvar Gosta Holger Sjoholm | Biologically active composition and the use thereof |
-
1977
- 1977-05-11 DE DE2721267A patent/DE2721267C2/de not_active Expired
-
1978
- 1978-04-19 GR GR56025A patent/GR64474B/el unknown
- 1978-04-20 FI FI781220A patent/FI781220A/fi not_active Application Discontinuation
- 1978-04-20 IL IL54558A patent/IL54558A/xx unknown
- 1978-04-21 AU AU35364/78A patent/AU519148B2/en not_active Expired
- 1978-04-24 AT AT0290978A patent/AT364856B/de not_active IP Right Cessation
- 1978-04-24 US US05/899,744 patent/US4235867A/en not_active Expired - Lifetime
- 1978-04-25 ZA ZA00782358A patent/ZA782358B/xx unknown
- 1978-04-26 DK DK181478A patent/DK181478A/da not_active Application Discontinuation
- 1978-04-26 CH CH454178A patent/CH637218A5/de not_active IP Right Cessation
- 1978-04-26 SE SE7804801A patent/SE7804801L/sv unknown
- 1978-04-26 NZ NZ187071A patent/NZ187071A/xx unknown
- 1978-04-26 LU LU79535A patent/LU79535A1/de unknown
- 1978-04-26 NO NO78781473A patent/NO781473L/no unknown
- 1978-04-26 NL NL7804466A patent/NL7804466A/xx not_active Application Discontinuation
- 1978-04-26 FR FR7812344A patent/FR2390731A1/fr active Granted
- 1978-04-26 BR BR7802600A patent/BR7802600A/pt unknown
- 1978-04-27 BE BE187209A patent/BE866491A/xx not_active IP Right Cessation
- 1978-04-27 DD DD78205046A patent/DD136185A5/xx unknown
- 1978-04-27 ES ES469830A patent/ES469830A1/es not_active Expired
- 1978-04-27 HU HU78CA424A patent/HU178485B/hu unknown
- 1978-04-27 JP JP5072678A patent/JPS5417116A/ja active Granted
- 1978-04-27 GB GB16822/78A patent/GB1603772A/en not_active Expired
- 1978-04-27 PL PL1978206415A patent/PL121950B1/pl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE2721267A1 (de) | 1978-11-23 |
| JPS5417116A (en) | 1979-02-08 |
| NZ187071A (en) | 1980-12-19 |
| CH637218A5 (de) | 1983-07-15 |
| PL121950B1 (en) | 1982-06-30 |
| GR64474B (en) | 1980-03-27 |
| FR2390731A1 (fr) | 1978-12-08 |
| BE866491A (fr) | 1978-08-14 |
| ATA290978A (de) | 1981-04-15 |
| DE2721267C2 (de) | 1985-05-02 |
| AT364856B (de) | 1981-11-25 |
| FI781220A (fi) | 1978-11-12 |
| HU178485B (en) | 1982-05-28 |
| LU79535A1 (de) | 1978-09-29 |
| GB1603772A (en) | 1981-11-25 |
| JPS6229747B2 (sv) | 1987-06-27 |
| BR7802600A (pt) | 1979-01-23 |
| NL7804466A (nl) | 1978-11-14 |
| SE7804801L (sv) | 1978-11-12 |
| DD136185A5 (de) | 1979-06-20 |
| IL54558A (en) | 1982-01-31 |
| PL206415A1 (sv) | 1980-11-17 |
| AU519148B2 (en) | 1981-11-12 |
| DK181478A (da) | 1978-11-12 |
| US4235867A (en) | 1980-11-25 |
| IL54558A0 (en) | 1978-07-31 |
| AU3536478A (en) | 1979-10-25 |
| FR2390731B1 (sv) | 1984-05-04 |
| ZA782358B (en) | 1979-04-25 |
| ES469830A1 (es) | 1978-12-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Dufau et al. | Radioimmunoassay of plasma testosterone | |
| NO781473L (no) | Polymermatriks basert paa akrylamid. | |
| US4450239A (en) | Method of determining pregnanediol in female urine and test device for use therein | |
| CN103940816A (zh) | 一种测定人体中甘胆酸含量的试剂盒及制备方法 | |
| JPS5896616A (ja) | 抗原、抗体またはハプテンの検出試薬およびそれに使用するラテックス並びにそれらの製法 | |
| EP0007654A1 (en) | Process for the detection and/or determination of components of the reaction between a specific binding protein and the corresponding bindable substance in an aqueous test sample; freeze-dried reagent and test kit to be used in the process | |
| US4299815A (en) | Carcinoembryonic antigen determination | |
| HOSODA et al. | Effect of bridge heterologous combination on sensitivity in enzyme immunoassay for cortisol | |
| US4235865A (en) | Method for the determination of unbound hormones and pharmaceuticals | |
| US4256724A (en) | Method for non-covalent coating of antibodies on solid substrates | |
| WO1983000505A1 (en) | Assay for viruses | |
| US4064227A (en) | Radioimmunoassay method for the determination of cardiotonic glycosides | |
| JPS6043361B2 (ja) | 親水性ラテックス粒子の製法 | |
| Levine et al. | Levels of 13, 14-dihydro-15-keto-PGF2α in biological fluids as measured by radioimmunoassay | |
| US3867518A (en) | Radioimmunoassay for insulin | |
| SU1213975A3 (ru) | Диагностикум дл количественного определени стероидного гормона в биологических жидкост х организма человека | |
| JPS6217189B2 (sv) | ||
| US3972992A (en) | Diagnostic test for opium alkaloids | |
| JP2947600B2 (ja) | 免疫測定法 | |
| US3888864A (en) | Amino lower alkyl ether derivatives of opium alkaloids | |
| CN109060782B (zh) | 一种猫早孕的发光检测试剂的制备方法及应用 | |
| US4066410A (en) | Thyroid hormone assay | |
| Moore Jr et al. | A solid-phase radioimmunoassay for estrogen by estradiol-17β antibody covalently bound to a water insoluble synthetic polymer (enzacryl AA) | |
| GB1588253A (en) | Immunoassay procedure and composite therefor | |
| Kiyohide et al. | Radioimmunoassay of 16α-hydroxy-dehydroepiandrosterone and its sulfate |